Citigroup Inc Dyne Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 64,438 shares of DYN stock, worth $872,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares

64,438

Previous 36,713 75.52%

Holding current value

$872,490

Previous $1.3 Million 78.69%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$31.94 - $47.04 $885,536 - $1.3 Million	27,725 Added 75.52%	64,438 $2.31 Million
Q2 2024 Aug 12, 2024	SELL	$23.65 - $35.63 $6.23 Million - $9.39 Million	-263,414 Reduced 87.77%	36,713 $1.3 Million
Q1 2024 May 10, 2024	BUY	$13.06 - $29.18 $2.98 Million - $6.67 Million	228,523 Added 319.15%	300,127 $8.52 Million
Q4 2023 Feb 09, 2024	BUY	$6.62 - $13.64 $64,273 - $132,430	9,709 Added 15.69%	71,604 $952,000
Q3 2023 Nov 09, 2023	BUY	$8.6 - $12.18 $98,968 - $140,167	11,508 Added 22.84%	61,895 $554,000
Q2 2023 Aug 10, 2023	BUY	$8.53 - $14.28 $391,885 - $656,051	45,942 Added 1033.57%	50,387 $566,000
Q1 2023 May 11, 2023	SELL	$10.88 - $15.0 $62,277 - $85,860	-5,724 Reduced 56.29%	4,445 $51,000
Q4 2022 Feb 09, 2023	SELL	$9.37 - $13.8 $1.09 Million - $1.61 Million	-116,409 Reduced 91.97%	10,169 $117,000
Q3 2022 Nov 10, 2022	SELL	$7.2 - $15.17 $1.99 Million - $4.19 Million	-276,078 Reduced 68.56%	126,578 $1.61 Million
Q2 2022 Aug 10, 2022	BUY	$4.36 - $10.5 $1.72 Million - $4.15 Million	395,230 Added 5322.25%	402,656 $2.77 Million
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $42,334 - $79,669	-6,493 Reduced 46.65%	7,426 $72,000
Q4 2021 Feb 10, 2022	BUY	$11.89 - $16.07 $120,421 - $162,756	10,128 Added 267.16%	13,919 $165,000
Q3 2021 Nov 10, 2021	BUY	$15.6 - $21.46 $59,139 - $81,354	3,791 New	3,791 $62,000

Others Institutions Holding DYN

# of Institutions

209

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $701M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account